GRAIL (company)
http://dbpedia.org/resource/GRAIL_(company) an entity of type: Thing
GRAIL is an American biotechnology company, which began in 2015 as a start-up in San Francisco, California, seeking to develop an early cancer screening test for people who do not have symptoms. Its headquarters is in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the UK. Its parent company is Illumina in San Diego, California.
rdf:langString
rdf:langString
GRAIL (company)
rdf:langString
GRAIL
rdf:langString
GRAIL
xsd:integer
65950478
xsd:integer
1107941359
xsd:integer
2015
rdf:langString
Menlo Park, California
rdf:langString
United States
rdf:langString
GRAIL logo.jpg
rdf:langString
[[#Galleri test
rdf:langString
American biotechnology company
rdf:langString
GRAIL is an American biotechnology company, which began in 2015 as a start-up in San Francisco, California, seeking to develop an early cancer screening test for people who do not have symptoms. Its headquarters is in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the UK. Its parent company is Illumina in San Diego, California. Their liquid biopsy, which was launched in June 2021 and is called the 'Galleri test', detects fragments of DNA in a blood sample via next-generation sequencing, which identifies DNA methylation, distinct patterns of which are associated with particular cancers, potentially allowing for the early detection of cancer and providing information of the origin of the cancer. It is one of three multicancer screening tests under investigation; the other two being the CancerSEEK assay and the PanSeer assay. On 27 November 2020, GRAIL announced a commercial partnership with the UK's National Health Service (NHS), to trial the Galleri test, to which several scientists have responded.
xsd:nonNegativeInteger
12098
xsd:gYear
2015